Titan Pharmaceuticals, Inc.  

(Public, NASDAQ:TTNP)   Watch this stock  
Find more results for OTC:TTNP
0.00 (0.00%)
Feb 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 3.45 - 8.74
Open     -
Vol / Avg. 0.00/87,467.00
Mkt cap 75.27M
P/E 16.72
Div/yield     -
EPS 0.22
Shares 21.20M
Beta 2.10
Inst. own 17%
Mar 13, 2017
Q4 2016 Titan Pharmaceuticals Inc Earnings Release (Estimated) Add to calendar
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin -10076.92% -674.99%
Operating margin -10061.54% -404.49%
EBITD margin - -383.06%
Return on average assets -43.04% -66.08%
Return on average equity -63.80% -144.59%
Employees 13 -
CDP Score - -


400 Oyster Point Blvd Ste 505
United States - Map
+1-650-2444990 (Phone)
+1-650-2444956 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Titan Pharmaceuticals, Inc. (Titan) is a specialty pharmaceutical company. The Company is engaged in developing therapeutics for the treatment of medical disorders. The Company's segment is engaged in the development of pharmaceutical products. The Company's product development programs utilize its long-term drug delivery platform, ProNeura. The Company's drug candidate, Probuphine, is being developed for the long-term maintenance treatment of opioid dependence. Titan's ProNeura continuous drug delivery system consists of a small, solid rod made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The Company focuses on developing two product development programs, the first one with a ropinirole implant for the treatment of Parkinson's disease (PD) and the second one with a Triiodothyronine (T3) implant for the treatment of hypothyroidism.

Officers and directors

Marc Rubin M.D. Executive Chairman of the Board
Age: 60
Bio & Compensation  - Reuters
Sunil Ramraje Bhonsle President, Director
Age: 65
Bio & Compensation  - Reuters
Rajinder Kumar Director
Age: 62
Bio & Compensation  - Reuters
Scott A. Smith Director
Age: 54
Bio & Compensation  - Reuters
Joseph A. Akers Independent Director
Age: 69
Bio & Compensation  - Reuters
Eurelio M. Cavalier Independent Director
Age: 82
Bio & Compensation  - Reuters
M. David David MacFarlane Ph.D. Independent Director
Age: 74
Bio & Compensation  - Reuters